tiprankstipranks
Trending News
More News >
OKYO Pharma Achieves Key Stability Milestone for Urcosimod
PremiumCompany AnnouncementsOKYO Pharma Achieves Key Stability Milestone for Urcosimod
1M ago
Okyo Pharma announces data on long-term stability of urcosimod
Premium
The Fly
Okyo Pharma announces data on long-term stability of urcosimod
1M ago
OKYO Pharma Seeks FDA Fast Track for Urcosimod in Treating Neuropathic Corneal Pain
Premium
Company Announcements
OKYO Pharma Seeks FDA Fast Track for Urcosimod in Treating Neuropathic Corneal Pain
2M ago
Yi Chen’s Buy Recommendation on OKYO Pharma: Promising Potential of OK-101 for Neuropathic Corneal Pain Amid Financial and Regulatory Challenges
PremiumRatingsYi Chen’s Buy Recommendation on OKYO Pharma: Promising Potential of OK-101 for Neuropathic Corneal Pain Amid Financial and Regulatory Challenges
3M ago
OKYO Pharma Executives Increase Shareholdings, Affirming Market Confidence
Premium
Company Announcements
OKYO Pharma Executives Increase Shareholdings, Affirming Market Confidence
3M ago
Okyo Pharma CEO purchases 10,000 shares of company
Premium
The Fly
Okyo Pharma CEO purchases 10,000 shares of company
3M ago
OKYO Pharma to Highlight Innovations at BTIG Conference
PremiumCompany AnnouncementsOKYO Pharma to Highlight Innovations at BTIG Conference
5M ago
OKYO Pharma Advances in Ocular Treatment Trials
Premium
Company Announcements
OKYO Pharma Advances in Ocular Treatment Trials
6M ago
OKYO Pharma Begins Key Trial for Eye Pain Therapy
Premium
Company Announcements
OKYO Pharma Begins Key Trial for Eye Pain Therapy
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100